This bill establishes a mandatory Radiation Oncology Case Rate Value Based Payment Program, providing per-episode payments to radiation therapy providers for Medicare patients, incentivizing quality and efficiency, and includes transportation support and exemptions from certain payment systems.
Thom Tillis
Senator
NC
The Radiation Oncology Case Rate Value Based Program Act of 2025 establishes a value-based payment model for radiation therapy under Medicare, providing per-episode payments to providers for cancer treatments. This program aims to improve the quality and efficiency of radiation oncology services while controlling costs, and includes incentives for meeting quality standards and offering patient-centered care, such as transportation assistance. The act also revises civil monetary penalties to allow transportation services for radiation oncology patients and exempts the program from budget neutrality adjustments. Most radiation therapy providers and suppliers will be required to participate in the program.
This bill, the "Radiation Oncology Case Rate Value Based Program Act of 2025," sets up a significant shift in how Medicare pays for radiation therapy for specific cancers. Instead of paying for each individual service (fee-for-service), it establishes a new system where providers receive a bundled, per-episode payment for a patient's entire course of treatment. The goal, according to the bill's findings, is to move towards valuing quality and efficiency over the sheer volume of services, aiming to control Medicare costs (which hit $4.2 billion for these services in 2021) while promoting patient-centered care.
Under this program, radiation therapy providers and suppliers treating Medicare patients for certain cancers would get a single payment amount for the entire treatment episode. This payment covers all related professional (doctor's work) and technical (equipment, facility use) services. Here's how it breaks down:
Participation isn't optional for most. The bill mandates that the majority of radiation therapy providers and suppliers join the program, though exceptions exist for those in certain other payment innovation models or facing undefined "significant hardships." Participating providers are required to offer payment plans for patient coinsurance amounts.
There are also quality components tied to payments:
A notable feature is the "Health Equity Add-on Payment." Providers can receive an extra $500 per patient episode (increasing by $10 annually) if they report that a patient faces transportation insecurity (using a specific diagnosis code, Z59.82). This money is intended to help cover transportation services for those patients.
Complementing this, Section 4 revises rules around civil monetary penalties. It creates an exception allowing providers (or other eligible entities) to offer free or discounted transportation (like ride shares or public transit vouchers, but not air or ambulance) to established radiation therapy patients living within 75 miles (or in a rural area). This is allowed if it's based on a consistent policy, isn't publicly advertised, drivers don't market services, and the provider bears the cost without shifting it to Medicare or patients.
Finally, Section 5 shields this program from certain budget calculations. Specifically, any savings generated by this new payment model won't be used by Medicare to reduce payments elsewhere under standard "budget neutrality" rules. This ensures the program's financial impact is considered separately when setting other Medicare payment rates.